Dianthus Therapeutics | MGTA - Assets

Stock Price
50.42
Daily Change
-2.04 -3.89%
Monthly
36.68%
Yearly
103.88%
Q1 Forecast
51.75

Dianthus Therapeutics reported $577.44M in Assets for its fiscal quarter ending in September of 2025.





Assets Change Date
Alaunos Therapeutics USD 3.72M 1.01M Sep/2025
Avita Medical AUD 58.13M 21.58M Jun/2025
Celltrion KRW 21.08T 530.63B Sep/2025
Cspc Pharmaceutical CNY 46B 1.61B Jun/2025
Dianthus Therapeutics USD 577.44M 251.37M Sep/2025
Divis Laboratories Ltd INR 181.51B 12.19B Sep/2025
IQVIA Holdings USD 28.73B 95M Sep/2025
Kangmei Pharma CNY 13.68B 38.19M Sep/2025
Knight Therapeutics CAD 962.29M 16.93M Sep/2024
Laboratorios Farma EUR 799.88M 99.95M Dec/2023
Malin Corporation EUR 198.5M 70.1M Dec/2024
Medical Developments International AUD 66.4M 1.06M Jun/2025
Moderna USD 12.14B 125M Sep/2025
Neuren Pharmaceuticals AUD 331.25M 78.46M Jun/2025
Organigram Holdings CAD 562.21M 2.4M Sep/2025
Organon & Co USD 13.55B 52M Sep/2025
Pharma Mar EUR 341.66M 6.59M Sep/2025
Qiagen NV USD 6.55B 729.74M Sep/2025
Revvity USD 12.14B 223.84M Sep/2025
Sartorius EUR 9.61B 413.4M Sep/2025
Sino Biopharmaceutical CNY 74.89B 9.49B Jun/2025
Tectonic Therapeutic USD 277M 18.31M Sep/2025
Tilray USD 2.07B 1.33B Mar/2025
Viatris USD 37.92B 491.1M Sep/2025
Xeris Pharmaceuticals USD 370.19M 35.5M Sep/2025
Zz Pientze Pharmaceu CNY 17.48B 1.23B Sep/2025